Daniel Abdun-Nabi, President and CEO at Emergent BioSolutions Inc. (EBS), sold 28,240 shares at $31.28 ($883K) on 2017-01-10, disclosed to the SEC on 2017-01-12.
Open-market sale of $883k EBS by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| EBS | SELL | 2018-09-06 | $5.5M | — | Filing → |
| EBS | SELL | 2018-06-07 | $823K | — | Filing → |
| EBS | SELL | 2018-01-04 | $1.0M | — | Filing → |